Dr. Jason Gerard Langenfeld, MD

Dr. Langenfeld practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Langenfeld's NPI, 1922068089, was assigned on March 24, 2006. Dr. Langenfeld holds Nebraska license 25051.

Dr. Langenfeld's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Langenfeld also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Langenfeld's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. The medical group on file is UNMC Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Langenfeld practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Langenfeld's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Langenfeld's licenses on file in 2 states: Nebraska and Michigan.

CMS data shows 177 Medicare services from Dr. Langenfeld across 3 procedure codes in 2024, for 179 Medicare patients. Medicare paid $21,017 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 179 Medicare patients who saw Dr. Langenfeld in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Langenfeld's median patient age at 66, with 51% women.

In 2024, Dr. Langenfeld wrote 14 Medicare Part D claims. 93% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $53 in total drug cost.

Dmand AI links 3 papers to Dr. Langenfeld, published from 2020 to 2024. The most frequent topics are COVID-19 and SARS-CoV-2. Dr. Langenfeld's most frequent co-authors are Chad E. Branecki, MD, Aaron Barksdale, MD and Abraham Stephen Campos, MD.

CMS Open Payments shows 4 general payments to Dr. Langenfeld from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $121.